These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29175090)

  • 1. Effect of fibrinogen, fibrin, and fibrin degradation products on transendothelial migration of leukocytes.
    Yakovlev S; Medved L
    Thromb Res; 2018 Feb; 162():93-100. PubMed ID: 29175090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual functions of the fibrin βN-domains in the VLDL receptor-dependent pathway of transendothelial migration of leukocytes.
    Yakovlev S; Medved L
    Thromb Res; 2022 Jun; 214():1-7. PubMed ID: 35421681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of VLDLR as a novel endothelial cell receptor for fibrin that modulates fibrin-dependent transendothelial migration of leukocytes.
    Yakovlev S; Mikhailenko I; Cao C; Zhang L; Strickland DK; Medved L
    Blood; 2012 Jan; 119(2):637-44. PubMed ID: 22096238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin-VLDL Receptor-Dependent Pathway Promotes Leukocyte Transmigration by Inhibiting Src Kinase Fyn and is a Target for Fibrin β15-42 Peptide.
    Yakovlev S; Cao C; Galisteo R; Zhang L; Strickland DK; Medved L
    Thromb Haemost; 2019 Nov; 119(11):1816-1826. PubMed ID: 31466086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-VLDL receptor monoclonal antibodies inhibit fibrin-VLDL receptor interaction and reduce fibrin-dependent leukocyte transmigration.
    Yakovlev S; Belkin AM; Chen L; Cao C; Zhang L; Strickland DK; Medved L
    Thromb Haemost; 2016 Nov; 116(6):1122-1130. PubMed ID: 27580629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current View on the Molecular Mechanisms Underlying Fibrin(ogen)-Dependent Inflammation.
    Yakovlev S; Strickland DK; Medved L
    Thromb Haemost; 2022 Nov; 122(11):1858-1868. PubMed ID: 35896433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of fibrin with VE-cadherin and anti-inflammatory effect of fibrin-derived fragments.
    Yakovlev S; Gao Y; Cao C; Chen L; Strickland DK; Zhang L; Medved L
    J Thromb Haemost; 2011 Sep; 9(9):1847-55. PubMed ID: 21752185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Fibrin with the Very Low-Density Lipoprotein (VLDL) Receptor: Further Characterization and Localization of the VLDL Receptor-Binding Site in Fibrin βN-Domains.
    Yakovlev S; Medved L
    Biochemistry; 2017 May; 56(19):2518-2528. PubMed ID: 28437098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of Fibrin with the Very Low Density Lipoprotein Receptor: Further Characterization and Localization of the Fibrin-Binding Site.
    Yakovlev S; Medved L
    Biochemistry; 2015 Aug; 54(30):4751-61. PubMed ID: 26153297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Basis for the Interaction of Fibrin with the Very Low-Density Lipoprotein Receptor Revealed by NMR and Site-Directed Mutagenesis.
    Gruschus JM; Yakovlev S; Banerjee K; Medved L; Tjandra N
    Biochemistry; 2021 Aug; 60(33):2537-2548. PubMed ID: 34351135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized fibrin(ogen) derivatives enhance the activity of tissue type plasminogen activator.
    Stief TW; Marx R; Heimburger N
    Thromb Res; 1989 Oct; 56(2):221-8. PubMed ID: 2515607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of fibrinogen BβN-domains.
    Medved L; Yakovlev S
    Ukr Biochem J; 2020; 92(3):22-32. PubMed ID: 37986735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo.
    Flick MJ; Du X; Witte DP; Jirousková M; Soloviev DA; Busuttil SJ; Plow EF; Degen JL
    J Clin Invest; 2004 Jun; 113(11):1596-606. PubMed ID: 15173886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of urinary protein C inhibitor to fibrin(ogen) and its binding mechanism.
    Hayashi S; Yamada K
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):153-8. PubMed ID: 8384496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo.
    Flick MJ; Du X; Degen JL
    Exp Biol Med (Maywood); 2004 Dec; 229(11):1105-10. PubMed ID: 15564436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen counteracts the antiadhesive effect of fibrin-bound plasminogen by preventing its activation by adherent U937 monocytic cells.
    Lishko VK; Yermolenko IS; Owaynat H; Ugarova TP
    J Thromb Haemost; 2012 Jun; 10(6):1081-90. PubMed ID: 22507544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of fibrinogen and its derivatives with fibrin.
    Husain SS; Weisel JW; Budzynski AZ
    J Biol Chem; 1989 Jul; 264(19):11414-20. PubMed ID: 2738072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear Magnetic Resonance Solution Structure of the Recombinant Fragment Containing Three Fibrin-Binding Cysteine-Rich Domains of the Very Low Density Lipoprotein Receptor.
    Banerjee K; Yakovlev S; Gruschus JM; Medved L; Tjandra N
    Biochemistry; 2018 Jul; 57(30):4395-4403. PubMed ID: 29965730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recalculation of calcium-binding properties of human and rat fibrin(ogen) and their degradation products.
    Nieuwenhuizen W; van Ruijven-Vermeer IA; Nooijen WJ; Vermond A; Haverkate F; Hermans J
    Thromb Res; 1981 Jun 1-25; 22(5-6):653-7. PubMed ID: 7302909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.